Claims for Patent: 11,266,799

Summary for Patent: 11,266,799

Title:	In-line nasal delivery device
Abstract:	A delivery device for a compound including: a housing, vial holding a compound; and a source of propellant, wherein the housing provides an inlet and an outlet for the vial, wherein the inlet is in fluid communication with the source of propellant and is directed against the in-line nasal delivery device compound and the outlet allows for delivery of the compound.
Inventor(s):	Fuller; Christopher (Seattle, WA), Hoekman; John D. (Seattle, WA), Kohring; Craig (Seattle, WA)
Assignee:	Impel Neuropharma, Inc. (Seattle, WA)
Application Number:	15/759,447
Patent Claims:	1. A device for the intranasal delivery of a compound comprising: a y-junction including a base, a first branch of the y-junction radiating from the base, a second branch of the y-junction radiating from the base, and a third branch of the y-junction radiating from the base; a vial containing the compound, the vial in fluid communication with the first branch of the y-junction; a metered dose pump to move the compound from the vial upon an actuation of the device; a dose chamber in fluid communication with the third branch of the y-junction, the dose chamber extending longitudinally from the third branch of the y-junction toward a nozzle, and the dose chamber to receive the compound pumped from the vial; the nozzle coupled with the dose chamber to provide an outlet from the dose chamber; a propellant canister in fluid communication with the second branch of the y-junction, the propellant canister containing a propellant in liquefied form; a diffuser configured to diffuse the propellant from the propellant canister following the actuation of the device; and an actuator coupled to the metered dose pump and to the propellant canister, the actuator configured to first actuate the metered dose pump to control movement of the compound from the vial into the dose chamber upon the actuation of the device, and the actuator further configured to subsequently control release of the propellant from the propellant canister, through the diffuser and into the dose chamber after a majority of the compound enters the dose chamber such that propellant pushes the compound as the compound exits the nozzle from the dose chamber. 2. The device of claim 1, further comprising a pump fitment securing the metered dose pump to the vial. 3. The device of claim 1, further including a check-valve coupled to the metered dose pump. 4. The device of claim 1, further including a nose cone in engagement with the nozzle. 5. The device of claim 1, wherein the diffuser is annular. 6. The device of claim 1, wherein the diffuser is a porous material. 7. The device of claim 1, wherein the diffuser forms the bottom of the dose chamber. 8. The device of claim 1, further comprising: an internal dose loading channel in a first path for the compound from the vial to the dose chamber, wherein the diffuser surrounds the internal dose loading channel in a second path for the propellant from the propellant canister to the dose chamber. 9. The device of claim 1, wherein an angle between the second branch of the y-junction and the third branch of the y-junction is an acute angle. 10. A device for the intranasal delivery of a compound to the olfactory region of the nasal cavity, the device comprising: a y-junction including a base, a first branch of the y-junction radiating from the base, a second branch of the y-junction radiating from the base, and a third branch of the y-junction radiating from the base; a vial containing the compound, the vial in fluid communication with the first branch of the y-junction; a metered dose pump to move the compound from the vial upon actuation of the device; a dose chamber in fluid communication with the third branch of the y-junction, the dose chamber extending longitudinally from the third branch of the y-junction toward a nozzle, and the dose chamber to receive the compound pumped from the vial; the nozzle coupled with the dose chamber to provide an outlet from the dose chamber; a propellant canister in fluid communication with the second branch of the y-junction, the propellant canister containing a propellant in a liquefied form; a diffuser configured to diffuse the propellant from the propellant canister following the actuation of the device; and an actuator coupled to the metered dose pump and to the propellant canister, the actuator configured to first actuate the metered dose pump to control movement of the compound from the vial into the dose chamber upon the actuation of the device, and the actuator further configured to subsequently control release of the propellant from the propellant canister and into the dose chamber after a majority of the compound enters the dose chamber such that the propellant pushes the compound as the compound exits the nozzle from the dose chamber. 11. The device of claim 10, wherein the propellant canister has a propellant valve for actuation by the actuator, the propellant canister in fluid communication with the dose chamber. 12. The device of claim 10, further comprising: an internal dose loading channel in a first path for the compound from the vial to the dose chamber, wherein the diffuser surrounds the internal dose loading channel in a second path for the propellant from the propellant canister to the dose chamber.